- 5 health systems shuttering ASCs
- Testosterone deficiency tied to up to $525B in healthcare costs
- Where US maternity care access stands in 2026
- 3 ASC closures in 1 week
- Could or should medical device representatives ever directly participate in surgical procedures? Opinion
- The $795M move turning Surgery Partners into a pure-play ASC operator
- 27 hospitals, health systems adding new C-suite roles in 2026
- ChristianaCare leader heads to Trinity Health
- 30 dental organizations among the fastest-growing US companies
- ‘Hospitals there are running out of options’: Nonprofit systems expand into Pennsylvania as for-profits exit
- Insurance industry losing jobs 4x faster than last year
- Court battles leaving the 340B program in legal limbo
- UM Health-Sparrow names 1st chaplain for community hospitals
- Ransomware breach at health IT vendor tops 3.8 million patients
- Illinois enacts law increasing oversight of private equity healthcare deals: 5 notes for dental leaders
- 51 behavioral health executive moves to know
- 5 data breaches in dentistry
- One-third of cardiologists are worth $5M or more: 10 things to know
- Rock Dental Brands partners with Florida specialty practice
- 3 Colorado practices accused of billing Medicare under deceased physician’s provider number
- ‘Feelings have no place’ in ASC expansion
- The ASC policy paradox
- 4 DSO giants getting bigger
- Kentucky nonprofit group to provide free surgeries to uninsured patients
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- 20 hospitals with the highest, lowest ED visit times for mental health patients
- Independent specialty practice joins McLeod Health
- The 1 word defining ASCs’ future: 42 leaders weigh in
- UVA psychiatry department names permanent chair after nearly a year as interim
- Maryland crisis center to lay off 62 after losing federal funding
- Henry Ford behavioral health pilot sees up to 85% drop in work queues after 1 year
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- The dental groups that will win the next wave of capital
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Flagler Health secures $50M series B for AI-native MSK care platform expansion
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Rogers Behavioral Health opens 2 residential treatment centers
- 5 controversies in dentistry
- New York directs $21M to psychiatric emergency care
- Where dental school tuition is dropping
- Where dental school tuition is rising
- Why young dentists are flocking to DSOs
- DC’s use of opioid settlement funds for Medicaid draws supplantation complaints
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Trump signs executive order to overhaul pediatric vaccine recommendations
- New audit framework finds AI chatbots reinforce mental health risk patterns: Study
- Texas residential mental health center to add 16 beds
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- The number of health plans reporting operating losses is growing: report
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston
- Sanders, Cassidy request DOJ update on contempt status of former Steward Health Care CEO
- Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Quanterix hires GE Healthcare, Exact Sciences alum as chief commercial officer
- Same Knee Surgery, Twice the Price: Hospital Monopolies Push Up Healthcare Costs
- Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach
- Doximity bets big on hospital adoption of enterprise AI as it ramps up tech spending
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Journalists Cover Cyclospora and Measles Outbreaks, and Changing Health Policies
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Industry Voices—AI won’t fix nurse burnout. Nurses will
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Insurers see positive results in managing health costs in Q2
- Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape
- UPMC, KLAS Research study examines AI adoption trends, governance barriers
- The AI boom could boost Epic's position, health system execs say. Here's where AI startups can still win
- Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
- Short-Term Vegan Diet Linked To Lower Inflammation And Aging
- Novo Nordisk makes Omnicom agency of record for US media buying
- Fresenius Kabi recalls mislabeled morphine lot that could cause overdose death
- Medicaid Work Rule Leaves Homeless People In The Cold
- Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
- Watch: Why Abortions Are on the Rise Since ‘Roe’ Was Overturned
- Budget Battle Erupts in Nation’s Capital Over Opioid Settlement Money
- AbbVie’s Skyrizi retakes edge in pharma’s July ad spending league
- Verily Me, Bausch + Lomb visualize dry eye education in new collaboration
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- UPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle
- Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy
- New bipartisan 340B reform bill curbs HHS' rebate pilot
- Inizio Engage expands medical information digs with Connected Insights platform
- Fierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat
- CCBHC model continues to expand, but faces some funding constraints
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- New CDC Director Dr. Erica Schwartz Takes Over
- Three Midlife Habits That Could Help Protect Your Brain
- The Next Frontier in Patient Support: Connected Data, AI and Personalized Engagement
- Senate committee advances Fauci contempt referral; Schwartz confirmed as new CDC director
- Millie joins UCSF Health's clinically integrated network to coordinate maternity care
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Oscar Health hikes 2026 outlook after record profitability during first half of the year
- Takeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful
- Sarepta’s new CEO Michael Severino faces critical milestones to prove growth
- Germs From Pet Dogs Might Protect Infants Against Infection, Researchers Say
- Want Strong Bones? Review Says Vigorous Sports Like Handball Beat Walking, Strength Training
- Parenting Can Offset ADHD Risk In Toddlers, Study Says
- Nurses Chase Cyclospora, Aided By Interviews, Fast-Food Receipts — And The Messy Details
- Listen to the Latest ‘KFF Health News Minute’
- Medicaid Work Rule Leaves Homeless People in the Cold
- Watch: Democratic Senator Proposes a Fix for American Healthcare — Covering All Kids
- On the heels of star rating win, Clover Health boosts outlook on strength of MA membership growth in Q2
- ViiV rolls out long-acting HIV campaign targeting ‘future you’
- Fitch: 2025 likely 'a brief operational peak' for nonprofit hospitals ahead of OBBBA changes
- HHS announces decertification of Kentucky-based organ procurement organization Network for Hope
- Autism Therapy Spending Quintuples, Prompting Federal Push For State Oversight
- Could The Air You Breathe Be Triggering Painful Arthritis Flares?
- Childhood Obesity Might Impact Women's Future Ability To Give Birth
- AI-Managed Oxygen Promotes More Stable Oxygen Levels In Patients
- Maja Pedersen named president, taking reins of Fujifilm's CDMO as CEO role is retired
- Type 2 Diabetes Might Make Menopause Worse
- ‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
- AI Is Being Used To Boost Medicaid Enrollment, But Not Without Concerns
- Pesticides Linked To Increased ALS Risk, Review Finds
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Inside Doctronic’s AI prescription refill pilot program in Utah
- Michigan Reports First U.S. Deaths From Parasite Outbreak
- Fierce Healthcare Data Breach Tracker: Unlimited Technology Systems hack impacts 3M
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
Michigan healthcare freedom community forum
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















